Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Lutz, Patrick" or (type any "bookEditor journalEditor issueEditor" and editor="Lutz, Patr...

Add to list
- Journal Article
- A1
- open access
Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

Veerle Mondelaers (UGent) , Stefan Suciu, Barbara De Moerloose (UGent) , Alina Ferster, Francoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, et al.

(2017) HAEMATOLOGICA. 102(10). p.1727-1738
Add to list
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

Pauline Simon, Stefan Suciu, Emmanuelle Clappier, Hélène Cave, Nicolas Sirvent, Geneviève Plat, Antoine Thyss, Françoise Mechinaud, Vitor M Costa, Alina Ferster, et al.

(2016) ANNALS OF HEMATOLOGY. 95(1). p.93-103
Add to list
Dexamethasone (6 mg/m²/day) and prednisolone (60 mg/m²/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Carine Domenech, Stefan Suciu, Barbara De Moerloose (UGent) , Françoise Mazingue, Geneviève Plat, Alina Ferster, Anne Uyttebroeck, Nicolas Sirvent, Patrick Lutz, Karima Yakouben, et al.

(2014) HAEMATOLOGICA. 99(7). p.1220-1227
Add to list
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Nicole Dastugue, Stefan Suciu, Geneviève Plat, Franki Speleman (UGent) , Hélène Cavé, Sandrine Girard, Marleen Bakkus, Marie Pierre Pagès, Karima Yakouben, Brigitte Nelken, et al.

(2013) BLOOD. 121(13). p.2415-2423
Add to list
- Conference Paper
- C3
Improved risk stratification and outcome prediction in children with average risk 1 precursor-B acute lymphoblastic leukemia using a 19-microRNA signature

Farzaneh Ghazavi (UGent) , Tim Lammens (UGent) , Stefan Suciu, Genevieve Laureys (UGent) , Marleen Bakkus, Alina Ferster, Anne Uyttebroeck, Patrick Lutz, Hélène Cavé, Geneviève Plat, et al.

(2012) European Hematology Association, 17th Congress, Abstracts.
Add to list
- Conference Paper
- C3
Improved risk-stratification and outcome prediction in children with average risk precursor-B acute lymphoblastic leukemia using a 19-microRNA signature

Farzaneh Ghazavi (UGent) , Tim Lammens (UGent) , Stefan Suciu, Genevieve Laureys (UGent) , Marleen Bakkus, Alina Ferster, Anne Uyttebroeck, Patrick Lutz, Hélène Cavé, Geneviève Plat, et al.

(2012) Belgian Hematological Society, 27th General annual meeting, Abstracts.
Add to list
Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951

Stéphane Ducassou, Céline Ferlay, Christophe Bergeron, Sandrine Girard, Genevieve Laureys (UGent) , Hélène Pacquement, Dominique Plantaz, Patrick Lutz, Jean-Pierre Vannier, Anna Uyttebroeck, et al.

(2011) BRITISH JOURNAL OF HAEMATOLOGY. 152(4). p.441-451
Add to list
Similar efficacy and toxicity profile for Idarubicine and Mitoxantrone in induction and intensification treatment of children with acute myeloid leukemia (AML) or myelodysplasia (MDS): long-term results of the EORTC-CLG randomized phase III trial 58921

Barbara De Moerloose (UGent) , Stefan Suciu, Martine Munzer, Caroline Piette, Karima Yakouben, Genevieve Margueritte, Patrick Lutz, Anne Uyttebroeck, Pierre Rohrlich, Alina Ferster, et al.

(2011) 53rd ASH annual meeting and exposition : abstracts, program and personal scheduler.
Add to list
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Barbara De Moerloose (UGent) , Stefan Suciu, Yves Bertrand, Françoise Mazingue, Alain Robert, Anne Uyttebroeck, Karima Yakouben, Alice Ferster, Geneviève Margueritte, Patrick Lutz, et al.

(2010) BLOOD. 116(1). p.36-44
Add to list
Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial

Anne Uyttebroeck, Stefan Suciu, Genevieve Laureys (UGent) , Alain Robert, Helene Pacquement, Alina Ferster, Genevieve Marguerite, Francoise Mazingue, Marleen Renard, Patrick Lutz, et al.

(2008) EUROPEAN JOURNAL OF CANCER. 44(6). p.840-846

Academic Bibliography

Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

Dexamethasone (6 mg/m²/day) and prednisolone (60 mg/m²/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Improved risk stratification and outcome prediction in children with average risk 1 precursor-B acute lymphoblastic leukemia using a 19-microRNA signature

Improved risk-stratification and outcome prediction in children with average risk precursor-B acute lymphoblastic leukemia using a 19-microRNA signature

Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951

Similar efficacy and toxicity profile for Idarubicine and Mitoxantrone in induction and intensification treatment of children with acute myeloid leukemia (AML) or myelodysplasia (MDS): long-term results of the EORTC-CLG randomized phase III trial 58921

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial

Contents

Support

Contact